SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-253381
Filing Date
2020-09-24
Accepted
2020-09-24 16:15:55
Documents
10
Period of Report
2020-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d27073d8k.htm   iXBRL 8-K 24951
  Complete submission text file 0001193125-20-253381.txt   142811

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200921.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200921_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200921_pre.xml EX-101.PRE 10948
5 EXTRACTED XBRL INSTANCE DOCUMENT d27073d8k_htm.xml XML 3274
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 201195452
SIC: 2835 In Vitro & In Vivo Diagnostic Substances